COVID-19 Clinical Trials: A Teachable Moment for Improving Our Research Infrastructure and Relevance.
editorial · Level V
Where this comes from
- Record sourced from PubMed, PMID 32543881.
- Also identified by DOI 10.7326/M20-2959 and PMC identifier 7322771.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The authors posit the need for rapid evaluation of therapies for COVID-19 as an inflection point spurring a much-needed rethinking of our research enterprise.
Medical subject headings
- Betacoronavirus
- Clinical Trials as Topic
- Coronavirus Infections
- Disease Management
- Pandemics
- Pneumonia, Viral